Induction of senescence-associated secretory phenotype underlies the therapeutic efficacy of PRC2 inhibition in cancer

• Liping Chu,
• Yuxiu Qu,
• Yang An,
• Linjun Hou,
• Juewan Li,
• Weijia Li,
• Gaofeng Fan,
• Bao-Liang Song,
• En Li,
• Liye Zhang,
• Wei Qi

Affiliations

Liping Chu

Gene Editing Center, School of Life Science and Technology, ShanghaiTech University

Yuxiu Qu

Gene Editing Center, School of Life Science and Technology, ShanghaiTech University

Yang An

Gene Editing Center, School of Life Science and Technology, ShanghaiTech University

Linjun Hou

Gene Editing Center, School of Life Science and Technology, ShanghaiTech University

Juewan Li

Gene Editing Center, School of Life Science and Technology, ShanghaiTech University

Weijia Li

Gene Editing Center, School of Life Science and Technology, ShanghaiTech University

Gaofeng Fan

Gene Editing Center, School of Life Science and Technology, ShanghaiTech University

Bao-Liang Song

Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University

En Li

China Novartis Institutes for BioMedical Research

Liye Zhang

Gene Editing Center, School of Life Science and Technology, ShanghaiTech University

Wei Qi

Gene Editing Center, School of Life Science and Technology, ShanghaiTech University